Enthesitis Assessment Before and After Anti-Tumor Necrosis Factor Treatment in Spondyloarthritis
Status:
Completed
Trial end date:
2018-01-01
Target enrollment:
Participant gender:
Summary
Biological therapies should be considered in patients with high disease activity despite
nonsteroid antiinflammatory drug treatment. The first option among biological therapies is
anti-Tumor Necrosis Factor (anti-TNF) drugs. In recent years, anti-TNF treatments have shown
that clinical and ultrasonographic enthesitis may improve as well as disease activity,
quality of life and acute phase reactants. In this prospective study, we aimed to evaluate
the clinical and ultrasonographic evaluation of enthesitis and to determine its response to
anti-TNF treatment in patients with SpA.In this prospective study, we aimed to evaluate the
clinical and ultrasonographic evaluation of enthesitis and to determine its response to
anti-TNF treatment in patients with SpA.